论文信息 - A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer. - 字舞流文

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer.

L. Seymour | H. Hirte | M. Moore | W. Walsh | E. Winquist | R. Patton | K. Chi | S. North | D. Ernst | J. Powers | T. Boucher